Kaleido Biosciences, Inc. Recorded Big Gain

Thu, May 05, 2022 at 05:30 PM
Kaleido Biosciences, Inc. Recorded Big Gain

Kaleido Biosciences, Inc. (KLDO:NASDAQ) rocketted at $0.1, a gain of 29.4%. On Wed, May 04, 2022, KLDO:NASDAQ touched a New 2-Week Intraday High of $0.08. From Thu, Apr 21, 2022, the stock recorded 11.11% Up Days and 20.00% Green Days

About Kaleido Biosciences, Inc. (KLDO:NASDAQ)

Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.